A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study von Drukker, C.A., Bueno‐de‐Mesquita, J.M., Retèl, V.P., Harten, W.H., Tinteren, H., Wesseling, J., Roumen, R.M.H., Knauer, M., Veer, L.J., Sonke, G.S., Rutgers, E.J.T., Vijver, M.J., Linn, S.C.

Volltext

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint® ) von Makama, M, Drukker, C.A, Rutgers, E.J.Th, Slaets, L, Cardoso, F, Rookus, M.A, Tryfonidis, K, Van't Veer, L.J, Schmidt, M.K

Volltext

Prospective cost-effectiveness analysis of genomic profiling in breast cancer von Retèl, V.P, Joore, M.A, Drukker, C.A, Bueno-de-Mesquita, J.M, Knauer, M, van Tinteren, H, Linn, S.C, van Harten, W.H

Volltext

Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature von Drukker, C.A, van den Hout, H.C, Sonke, G.S, Brain, E, Bonnefoi, H, Cardoso, F, Goldhirsch, A, Harbeck, N, Honkoop, A.H, Koornstra, R.H.T, van Laarhoven, H.W.M, Portielje, J.E.A, Schneeweiss, A, Smorenburg, C.H, Stouthard, J, Linn, S.C, Schmidt, M.K

Volltext

207 70-Gene Signature Prospectively Predicts Prognosis of Patients with Node-negative Breast Cancer: 5 Year Follow-up of the RASTER Study von Linn, S.C, Drukker, C.A, Retel, V.P, Bueno-de-Mesquita, J.M, van Harten, W.H, van Tinteren, H, Wesseling, J, van't Veer, L.J, Rutgers, E.J.T, van de Vijver, M.J

Volltext

Management of Phyllodes tumors: a Dutch population-based retrospective cohort between 1989 and 2022 von Van Olmen, J., Bartels, S.A.L., Beerthuizen, A.W.J., Bekers, E.M., Scholten, A.N., Drukker, C.A., Vrancken Peeters, M.J.T.F.D., van Duijnhoven, F.H.

Volltext

LBA11 Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in triple negative breast cancer with high tumor-infiltrating lymphocytes (TILs) von Nederlof, I., Rolfes, A.L., Gielen, R.C.A.M., Awada, G., Dongen, M.V., Horlings, H.M., Van De Vijver, K., Drukker, C.A., van Duijnhoven, F., Lopez-Yurda, M., Mandjes, I., Mann, R.M., Loo, C.E., Blank, C.U., Schumacher, T.N., Salgado, R.F., Kok, M.

Volltext

Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial von Lopes Cardozo, J.M.N., Byng, D., Drukker, C.A., Schmidt, M.K., Binuya, M.A., van ’t Veer, L.J., Cardoso, F., Piccart, M., Smorenburg, C.H., Poncet, C., Rutgers, E.J.T.

Volltext

120P Impact of PET-CT and neoadjuvant systemic treatment in patients with stage I HER2+ breast cancer von van Olmen, J.P., Geurts, V.C.M., Drukker, C.A., Peeters, M-J.T.F.D. Vrancken, Kok, M., van Duijnhoven, F.H.

Volltext

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis von Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van ’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Volltext

Long-term impact of the 70-gene signature on breast cancer outcome von Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th, Bernards, R., van de Vijver, M. J., van’t Veer, L. J.

Volltext

Mammographic screening detects low-risk tumor biology breast cancers von Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J.

Volltext

Corrigendum to “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature... von Makama, M., Drukker, C.A., Rutgers, E.J.Th, Slaets, L., Cardoso, F., Rookus, M.A., Tryfonidis, K., Van't Veer, L.J., Schmidt, M.K.

Volltext

Enrichment of high-grade tumors in breast cancer gene expression studies von van Seijen, M., Mooyaart, A. L., Mulder, L., Hoogstraat, M., Drukker, C. A., Loo, C. E., Pouw, B., Sonke, G. S., Wesseling, J., Lips, E. H.

Volltext

Changes over time in the impact of gene‐expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A natio... von Kuijer, A., Drukker, C.A., Elias, S.G., Smorenburg, C.H., Th. Rutgers, E.J., Siesling, S., van Dalen, Th

Volltext

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherap... von Kuijer, A., van Bommel, A.C.M., Drukker, C.A., van der Heiden-van der Loo, M., Smorenburg, C.H., Westenend, P.J., Linn, S.C., Rutgers, E.J.Th, Elias, S.G., van Dalen, Th

Volltext

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms von Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.

Volltext

Automated Method for Improving System Performance of Computer-Aided Diagnosis in Breast Ultrasound von Drukker, K., Sennett, C.A., Giger, M.L.

Volltext